Form 10-K405 - Annual report [Sections 13 and 15(d), S-K Item 405]:
SEC Accession No. 0000912057-02-009284
Filing Date
2002-03-11
Accepted
2002-03-11 00:00:00
Documents
9
Period of Report
2001-12-31

Document Format Files

Seq Description Document Type Size
1 10-K405 a2072779z10-k405.htm 10-K405 771830
3 EXHIBIT 4.4 a2072779zex-4_4.txt EX-4.4 45569
4 EXHIBIT 4.5 a2072779zex-4_5.txt EX-4.5 262414
5 EX-10.16 a2072779zex-10_16.txt EX-10.16 150077
6 EX-10.26 a2072779zex-10_26.txt EX-10.26 31854
7 EX-10.27 a2072779zex-10_27.txt EX-10.27 106357
8 EX-10.37 a2072779zex-10_37.txt EX-10.37 175117
9 EXHIBIT 21.1 a2072779zex-21_1.txt EX-21.1 3848
10 EXHIBIT 23.1 a2072779zex-23_1.txt EX-23.1 473
  Complete submission text file 0000912057-02-009284.txt   1549938
Mailing Address 1600 FARADAY AVE CARLSBAD CA 92008
Business Address 1600 FARADAY AVE CARLSBAD CA 92008 7606037200
INVITROGEN CORP (Filer) CIK: 0001073431 (see all company filings)

EIN.: 330373077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K405 | Act: 34 | File No.: 000-25317 | Film No.: 02571484
SIC: 2836 Biological Products, (No Diagnostic Substances)